cerrar
Tagged with clinical trials,

Interview: Endang Hoyaranda, President Director, Prodia Group,…
Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote…

The future of innovation in Ireland
With budget cuts in response to the financial crisis barely touching the science sector, could it be that innovative pharmaceutical companies could…

Interview: Ming-Chu Hsu, Chairman & CEO, TaiGen…
TaiGen is on the brink of releasing Taiwan’s first innovative drug. In this interview, the Chairman and CEO of the company discusses the development…

Interview: Ellson Chen, President & CEO, Vita Genomics,…
The President & CEO of Vita Genomics talks about the advantages that genomic testing offer both to sick and healthy patients, as well as the…

Interview: Stanley Chang Chairman and CEO, Medigen Biotechnology…
The chairman and CEO of Medigen shares his insights on a significant past three years for the company, which included both an IPO and major…

Interview with Ivan Y. Zhai, CEO and Major Founder, GCP CMIC…
You are the CEO of GCP CMIC ClinPlus in addition to R&G PharmaStudies, and before that you headed a number of companies as well. Could you…

Interview with Sang Goo Shin, President, Korea National…
Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick evolution? Clinical…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here